文献速递生殖医学

胚胎植入前非整倍体遗传学检测与新鲜供卵体外受精周期活产率降低相关,而与冷冻供卵周期无关:对辅助生殖技术临床结局报告系统报告的18,562个供卵周期的分析

Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System.
PubMed 文献 · Fertil Steril · 2024-08-10

该回顾性队列研究分析辅助生殖技术临床结局报告系统数据库中11,348个新鲜和7,214个冷冻供卵体外受精周期,比较使用与不使用胚胎植入前非整倍体遗传学检测(PGT-A)的第一移植活产率和累积活产率。新鲜供卵周期中PGT-A与第一移植活产率(46.9% vs 53.2%)和累积活产率(58.4% vs 66.6%)降低相关;冷冻供卵周期中PGT-A组活产率名义上较高(48.3% vs 40.5%)但多因素回归未达统计学显著。

要点

  • 新鲜供卵周期中,使用PGT-A与第一移植活产率降低相关(46.9% vs 53.2%)。
  • 新鲜供卵周期中,使用PGT-A与累积活产率降低相关(58.4% vs 66.6%)。
  • 冷冻供卵周期中PGT-A组活产率名义上较高但未达统计学显著(48.3% vs 40.5%)。

核心结论

  • 新鲜供卵周期中胚胎植入前非整倍体遗传学检测与活产率和累积活产率降低相关,而对冷冻供卵周期的影响临床上可忽略。

研究设计与样本

  • 回顾性队列研究,分析辅助生殖技术临床结局报告系统数据库。
  • 共分析11,348个新鲜供卵体外受精周期和7,214个冷冻供卵体外受精周期。
  • 纳入2014年1月1日至2015年12月31日期间每例患者首个报告的供卵刺激周期,以及2014年1月1日至2016年12月31日期间所有关联的胚胎移植周期。
  • 采用逻辑回归模型校正年龄、体重指数、孕次、不孕病因和既往体外受精周期数。

主要发现

  • 在新鲜供卵周期中,与未使用PGT-A相比,使用PGT-A与第一移植活产率降低相关(46.9% vs 53.2%)和累积活产率降低相关(58.4% vs 66.6%)。
  • 在冷冻供卵周期中,PGT-A组活产率名义上高于未使用PGT-A组(48.3% vs 40.5%),但在多因素逻辑回归模型中未达统计学显著。
  • 使用与未使用PGT-A的早期妊娠丢失无显著差异。
  • 新鲜供卵周期中加用PGT-A后多胎妊娠、早产和低出生体重儿均减少,但比较新鲜供卵周期单胚胎移植时这些结局无显著差异,冷冻供卵周期中亦无显著差异。

临床怎么用

  • 作者认为新鲜供卵周期中PGT-A与活产率和累积活产率降低相关,冷冻供卵周期中的影响临床上可忽略。
  • 作者认为新鲜供卵周期中PGT-A相关的产科获益似乎与增加单胚胎移植有关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of preimplantation genetic testing for aneuploidy (PGT-A) on first transfer live birth rate (LBR) and cumulative LBR (CLBR) in donor oocyte in vitro fertilization (IVF) cycles. DESIGN: Retrospective cohort study of the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database. SETTING: Fertility centers reporting to Society for Assisted Reproductive Technology. PATIENT(S): A total of 11,348 fresh and 7,214 frozen-thawed donor oocyte IVF cycles were analyzed. INTERVENTION(S): The first reported donor stimulation cycle per patient between January 1, 2014, and December 31, 2015, and all linked embryo transfer cycles between January 1, 2014, and December 31, 2016, were included in the study. MAIN OUTCOME MEASURE(S): Live birth rate was compared for patients using fresh and frozen-thawed donor oocytes, with or without PGT-A. Logistic regression models were adjusted for age, body mass index, gravidity, infertility etiology, and prior IVF cycles. RESULT(S): Among patients who had blastocysts available for transfer or PGT-A, the use of PGT-A was associated with a decreased first transfer LBR (46.9 vs. 53.2%) and CLBR (58.4 vs. 66.6%) in fresh oocyte donor cycles compared with no PGT-A. Live birth rate in frozen-thawed oocyte donor cycles with PGT-A were nominally higher than those without PGT-A (48.3% vs. 40.5%) but were not statistically significant in multivariable logistic regression models. Early pregnancy loss was not significantly different with and without PGT-A. Multiple gestation, preterm birth, and low birth weight infants were all reduced with the addition of PGT-A in fresh donor oocyte cycles, although these outcomes were not significantly different when comparing single embryo transfers in fresh oocyte cycles and also not significantly different among frozen-thawed donor oocyte cycles. CONCLUSION(S): Preimplantation genetic testing for aneuploidy in fresh oocyte donor cycles was associated with decreased LBR and CLBR, whereas effects on frozen-thawed oocyte donor cycles were clinically negligible. Obstetric benefits associated with PGT-A in fresh donor cycles appear linked to increased single embryo transfer.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Gingold JA, Kucherov A, Wu H, et al. Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril. 2024. PMID: 39128672. doi:10.1016/j.fertnstert.2024.08.315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。